Fortrea Holdings (FTRE) Free Cash Flow (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Free Cash Flow came in at $19.9 million in Q2 2026, up 39.16% YoY from $14.3 million in Q2 2025, and up 179.6% on a QoQ basis from -$25.0 million in Q1 2026.
Fortrea Holdings (FTRE) Free Cash Flow (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Free Cash Flow data on file, last reported at $19.9 million in Q2 2026.
- Quarterly Free Cash Flow rose 39.16% year-over-year to $19.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $196.0 million (up 290.11% YoY) and the FY2025 annual result came in at $88.3 million, down 62.79% from the prior year.
- Free Cash Flow climbed to $19.9 million in Q2 2026, from -$25.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $262.5 million in Q2 2024 to a low of -$127.1 million in Q1 2025.
- A 5-year average of $32.4 million and a median of $11.6 million in 2023 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 850.0% in 2025, down 264.18% in 2025.
- Tracing FTRE's Free Cash Flow over 5 years: stood at $5.1 million in 2022, then soared by 76.47% to $9.0 million in 2023, then jumped by 125.56% to $20.3 million in 2024, then jumped by 499.01% to $121.6 million in 2025, then sank by 83.63% to $19.9 million in 2026.
- The last three Free Cash Flow figures came in at $19.9 million (Q2 2026), -$25.0 million (Q1 2026), and $121.6 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | 19.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.90 Mn |
| Jun 30, 2026 | 19.90 Mn |
| Mar 31, 2026 | -25.00 Mn |
| Mar 31, 2026 | -25.00 Mn |
| Dec 31, 2025 | 121.60 Mn |
| Dec 31, 2025 | 121.60 Mn |
| Sep 30, 2025 | 79.50 Mn |
| Sep 30, 2025 | 79.50 Mn |
| Jun 30, 2025 | 14.30 Mn |
| Jun 30, 2025 | 14.30 Mn |
| Mar 31, 2025 | -127.10 Mn |
| Mar 31, 2025 | -127.10 Mn |
| Dec 31, 2024 | 20.30 Mn |
| Dec 31, 2024 | 20.30 Mn |
| Sep 30, 2024 | -10.60 Mn |
| Sep 30, 2024 | -10.60 Mn |
| Jun 30, 2024 | 262.50 Mn |
| Jun 30, 2024 | 262.50 Mn |
| Mar 31, 2024 | -34.90 Mn |
| Mar 31, 2024 | -34.90 Mn |